## Inpatient IV Regimen for Severe PID with Peritonitis **Key Point:** For hospitalized PID with peritonitis and hemodynamic instability, the CDC recommends clindamycin + gentamicin (± ampicillin) as first-line IV therapy. This combination provides broad anaerobic, gram-negative, and gram-positive coverage. ### Rationale for Clindamycin + Gentamicin 1. **Clindamycin 900 mg IV Q8H** — excellent anaerobic coverage (critical in peritonitis); good pelvic penetration; covers gram-positive cocci. 2. **Gentamicin 2 mg/kg IV Q8H** — covers aerobic gram-negative rods including *E. coli*, *Klebsiella*, *Proteus*; synergistic with clindamycin. 3. **Ampicillin 2 g IV Q6H (optional)** — added if enterococcal coverage is desired (especially post-procedural or with bowel perforation). ### Spectrum Comparison | Regimen | Anaerobes | Gram-Neg | Gram-Pos | Enterococcus | Chlamydia | |---------|-----------|----------|----------|--------------|----------| | Clindamycin + Gentamicin | ✓ | ✓ | ✓ | ✗ | ✗ | | Clindamycin + Gentamicin + Ampicillin | ✓ | ✓ | ✓ | ✓ | ✗ | | Cefotetan + Doxycycline | ✓ | ✓ | ✓ | ✗ | ✓ | | Meropenem | ✓ | ✓ | ✓ | ✓ | ✗ | **High-Yield:** Clindamycin + gentamicin is the CDC-preferred regimen for hospitalized PID with peritonitis. Doxycycline is added after clinical improvement to cover *Chlamydia* (step-down therapy). **Mnemonic:** **CLINDA-GENT** = Clindamycin (anaerobes) + Gentamicin (gram-negatives) for severe intra-abdominal infection. **Clinical Pearl:** Gentamicin dosing is weight-based and renal function–dependent. Peak and trough levels should be monitored in severe infection. Transition to oral doxycycline once fever resolves and oral intake is tolerated. [cite:CDC STI Treatment Guidelines 2021; ACOG Practice Bulletin 110]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.